TrialAdvances in therapy2014

A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.

Norbert Pfeiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.